CXCL10 and systemic sclerosis: To determine whether sildenafil could target the intracellular paths underlying CXCL10 release in SSc Hdfbs, we evaluated STAT-1, JNK and NF-kB phosphorylation with or without sildenafil (1 μM) using healthy Hdfbs for comparison.